Mesotocin presents a cyclic peptide architecture containing cysteine residues forming a stabilizing disulfide bond. Residue diversity shapes conformational rigidity and receptor-binding behavior. Researchers examine its folding, charge distribution, and structural transitions. Applications include peptide-analogue design, structural biology, and ligand-modeling studies.
CAT No: R2677
CAS No:362-39-0
Synonyms/Alias:mesotocin;362-39-0;8-Ile-oxytocin;(Ile8)-Oxytocin;Oxytocin, ile(8)-;Oxytocin, isoleucine(8)-;Oxytocin, 8-L-isoleucine-;UNII-3Y635KQT1J;3Y635KQT1J;MESOTOCIN [WHO-DD];8-ISOLEUCINE OXYTOCIN;(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S,3S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;Mesotocin trifluroacetate;HY-P4605;FI108690;CS-0655396;Q27258201;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.